These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16386623)

  • 1. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation.
    Sarmiento E; Rodríguez-Molina J; Muñoz P; Fernández-Yánez J; Palomo J; Fogueda M; Fernández-Cruz E; Bouza E; Carbone J
    Transplant Proc; 2005 Nov; 37(9):4046-9. PubMed ID: 16386623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG monitoring to identify the risk for development of infection in heart transplant recipients.
    Sarmiento E; Rodriguez-Molina JJ; Fernandez-Yañez J; Palomo J; Urrea R; Muñoz P; Bouza E; Fernandez-Cruz E; Carbone J
    Transpl Infect Dis; 2006 Mar; 8(1):49-53. PubMed ID: 16623821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
    Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections.
    Carbone J; Sarmiento E; Palomo J; Fernandez-Yañez J; Muñoz P; Bouza E; Rodríguez-Molina J; Lanio N; Fernandez-Cruz E
    Transplant Proc; 2007 Sep; 39(7):2385-8. PubMed ID: 17889198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an immunological score to assess the risk of severe infection in heart recipients.
    Sarmiento E; Navarro J; Fernandez-Yañez J; Palomo J; Muñoz P; Carbone J
    Transpl Infect Dis; 2014 Oct; 16(5):802-12. PubMed ID: 25179534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection.
    Carbone J; Micheloud D; Salcedo M; Rincon D; Bañares R; Clemente G; Jensen J; Sarmiento E; Rodriguez-Molina J; Fernandez-Cruz E
    Transpl Infect Dis; 2008 Dec; 10(6):396-402. PubMed ID: 18657086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay.
    Cadillo-Chávez R; de Echegaray S; Santiago-Delpín EA; Rodríguez-Trinidad AT; Camacho-Carrazo B; Alfaro T; Saavedra-Pozo M; Carrasquillo L; González-Caraballo ZA; Morales-Otero LA
    Transplant Proc; 2006 Apr; 38(3):918-20. PubMed ID: 16647510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Chlamydia pneumoniae infection on survival rate after heart transplantation.
    Pieniazek P; Stepień E; Sadowski J; Przewłocki T; Sokołowski A; Podolec P; Kapelak B; Przybyłowski P; Kadzielski A; Tracz W
    Med Sci Monit; 2003 Feb; 9(2):CR67-72. PubMed ID: 12601289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
    Iberer F; Halwachs-Baumann G; Rödl S; Pleisnitzer A; Wasler A; Auer T; Petutschnigg B; Müller H; Tscheliessnigg K; Wilders-Truschnig M
    J Heart Lung Transplant; 1994; 13(3):405-11. PubMed ID: 8061015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypogammaglobulinemia in liver transplant recipients: incidence, timing, risk factors, and outcomes.
    Doron S; Ruthazer R; Werner BG; Rabson A; Snydman DR
    Transplantation; 2006 Mar; 81(5):697-703. PubMed ID: 16534471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited cytomegalovirus-specific immunoglobulin M and immunoglobulin G profiles in heart transplant recipients.
    Allen MD; Denny CF; Kruse AP; Revkin JH; Fishbein DP; Ashley RL
    J Heart Lung Transplant; 1991; 10(5 Pt 1):664-73. PubMed ID: 1659902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
    Potena L; Holweg CT; Chin C; Luikart H; Weisshaar D; Narasimhan B; Fearon WF; Lewis DB; Cooke JP; Mocarski ES; Valantine HA
    Transplantation; 2006 Aug; 82(3):398-405. PubMed ID: 16906040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypogammaglobulinemia: Incidence, risk factors, and outcomes following pediatric lung transplantation.
    Robertson J; Elidemir O; Saz EU; Gulen F; Schecter M; McKenzie E; Heinle J; Smith E; Mallory G
    Pediatr Transplant; 2009 Sep; 13(6):754-9. PubMed ID: 19067916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-course changes of serum immunoglobulins (IgA, IgG, IgM) after liver transplantation for alcoholic cirrhosis.
    González-Quintela A; López-Ben S; Pérez LF; Graña B; Varela M; Tomé S; Varo E
    Transpl Immunol; 2003; 11(1):73-7. PubMed ID: 12727478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer?
    Muñoz P; Giannella M; Alcalá L; Sarmiento E; Fernandez Yañez J; Palomo J; Catalán P; Carbone J; Bouza E
    J Heart Lung Transplant; 2007 Sep; 26(9):907-14. PubMed ID: 17845929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
    Bonaros N; Mayer B; Schachner T; Laufer G; Kocher A
    Clin Transplant; 2008; 22(1):89-97. PubMed ID: 18217909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.
    Carbone J; Sarmiento E; Del Pozo N; Rodriguez-Molina JJ; Navarro J; Fernandez-Yañez J; Palomo J; Villa A; Muñoz P; Fernandez-Cruz E
    Clin Transplant; 2012; 26(3):E277-83. PubMed ID: 22686951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients.
    Sarmiento E; del Pozo N; Gallego A; Fernández-Yañez J; Palomo J; Villa A; Ruiz M; Muñoz P; Rodríguez C; Rodríguez-Molina J; Navarro J; Kotsch K; Fernandez-Cruz E; Carbone J
    Transpl Infect Dis; 2012 Oct; 14(5):526-39. PubMed ID: 23013361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients.
    Hoppe L; Marroni CA; Bressane R; Lago L; Schiavo FL; Cigerza GC; Brandão AB; Zanotelli ML; Cantisani GP
    Transplant Proc; 2006; 38(6):1922-3. PubMed ID: 16908324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.